|Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement|
D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Systematic reviews 4 (1), 1-9, 2015
|Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation|
L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Bmj 349, 2015
|ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions|
JAC Sterne, MA Hernßn, BC Reeves, J Savović, ND Berkman, ...
bmj 355, 2016
|Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide|
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
|SPIRIT 2013 statement: defining standard protocol items for clinical trials|
AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC G°tzsche, ...
Annals of internal medicine 158 (3), 200-207, 2013
|SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials|
AW Chan, JM Tetzlaff, PC G°tzsche, DG Altman, H Mann, JA Berlin, ...
Bmj 346, 2013
|Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles|
AW Chan, A Hrˇbjartsson, MT Haahr, PC G°tzsche, DG Altman
Jama 291 (20), 2457-2465, 2004
|Systematic review of the empirical evidence of study publication bias and outcome reporting bias|
K Dwan, DG Altman, JA Arnaiz, J Bloom, AW Chan, E Cronin, E Decullier, ...
PloS one 3 (8), e3081, 2008
|Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review|
K Dwan, C Gamble, PR Williamson, JJ Kirkham, Reporting Bias Group
PloS one 8 (7), e66844, 2013
|Biomedical research: increasing value, reducing waste|
MR Macleod, S Michie, I Roberts, U Dirnagl, I Chalmers, JPA Ioannidis, ...
The Lancet 383 (9912), 101-104, 2014
|Increasing value and reducing waste: addressing inaccessible research|
AW Chan, F Song, A Vickers, T Jefferson, K Dickersin, PC G°tzsche, ...
The Lancet 383 (9913), 257-266, 2014
|Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors|
AW Chan, DG Altman
Bmj 330 (7494), 753, 2005
|The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed|
S Hopewell, S Dutton, LM Yu, AW Chan, DG Altman
Bmj 340, 2010
|Epidemiology and reporting of randomised trials published in PubMed journals|
AW Chan, DG Altman
The Lancet 365 (9465), 1159-1162, 2005
|Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension|
M Calvert, D Kyte, R Mercieca-Bebber, A Slade, AW Chan, MT King, ...
Jama 319 (5), 483-494, 2018
|Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research|
AW Chan, K Krleža-Jerić, I Schmid, DG Altman
Cmaj 171 (7), 735-740, 2004
|Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension|
X Liu, SC Rivera, D Moher, MJ Calvert, AK Denniston, H Ashrafian, ...
The Lancet Digital Health 2 (10), e537-e548, 2020
|Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension|
SC Rivera, X Liu, AW Chan, AK Denniston, MJ Calvert, H Ashrafian, ...
The Lancet Digital Health 2 (10), e549-e560, 2020
|Ghost authorship in industry-initiated randomised trials|
PC G°tzsche, A Hrˇbjartsson, HK Johansen, MT Haahr, DG Altman, ...
PLoS medicine 4 (1), e19, 2007
|Design, analysis, and presentation of crossover trials|
EJ Mills, AW Chan, P Wu, A Vail, GH Guyatt, DG Altman
Trials 10, 1-6, 2009